Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/12349
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAkarasakul D.
dc.contributor.authorViriyasiripong S.
dc.date.accessioned2021-04-05T03:02:53Z-
dc.date.available2021-04-05T03:02:53Z-
dc.date.issued2019
dc.identifier.issn1252208
dc.identifier.other2-s2.0-85070491879
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/12349-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85070491879&partnerID=40&md5=89bcead85223aab30189d70275478b5d
dc.description.abstractObjective: To study the prostate cancer detection rates upon transrectal ultrasound (TRUS) guided biopsy in relation to prostate-specific antigen (PSA) and digital rectal examination (DRE) included risk factors for prostate cancer diagnosis. Materials and Methods: 1,176 patients who underwent TRUS prostate biopsy between 2002 to 2008 were enrolled to the study. The prostate cancer detection rates with reference to PSA level and DRE finding were investigated. Logistic regression analysis was performed on age at biopsy, clinical symptoms, prostate-specific antigen (PSA), and DRE findings to identify significant risk factors. The correlation of DRE findings in combination with PSA value was also analyzed. Results: Referring to patients with normal DRE, the cancer detection rates were 10.8%, 12.9%, 21.3%, 42.6% and 77.8% in patients with PSA <4, 4 to 10, 10.01 to 20, 20.01 to 50 and >50 ng/ml, respectively. According to patients with abnormal DRE, the cancer detection rates were 15.0%, 20.7%, 41.2%, 60.5% and 84.8% in patients with PSA <4, 4 to 10, 10.01 to 20, 20.01 to 50 and >50 ng/ ml, respectively. Additionally, the age at biopsy, PSA level and DRE finding were the significant risk factors for prostate cancer diagnosis while clinical symptom was not. The data revealed that normal DRE finding in combination with PSA level was statistically significant when PSA level was above 20 ng/ml. Similarly, the abnormal DRE finding in combination with PSA level was statistically significant when PSA level was above 10 ng/ml. Conclusion: Thai men appeared to have lower prostate cancer detection rate when compared to the Western population. The age at biopsy, PSA level and DRE finding were the significant risk factors for prostate cancer. Besides, the combination of DRE and PSA level increased the accuracy and were the best tool for prostate cancer screening. © JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND| 2019.
dc.subjectciprofloxacin
dc.subjectprostate specific antigen
dc.subjectadult
dc.subjectage
dc.subjectaged
dc.subjectArticle
dc.subjectcancer diagnosis
dc.subjectcancer risk
dc.subjectcontrolled study
dc.subjectdigital rectal examination
dc.subjecthuman
dc.subjecthuman tissue
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmiddle aged
dc.subjectprostate biopsy
dc.subjectprostate cancer
dc.subjectrisk factor
dc.subjectThai (people)
dc.subjecttransrectal ultrasonography
dc.subjectvery elderly
dc.titleProstate cancer diagnosis-what to expect in the thai population?
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of the Medical Association of Thailand. Vol 102, No.7 (2019), p.58-61
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.